{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 458268975
| IUPAC_name = Pegylated E. coli L-asparagine amidohydrolase
| image =  
<!-- Clinical data -->
| tradename =  
| Drugs.com = {{drugs.com|monograph|pegaspargase}}
| MedlinePlus = a695031
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = C
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = Rx-only
| legal_status =  
| routes_of_administration =  
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 130167-69-0
| ATC_prefix = L01
| ATC_suffix = XX24
| ATC_supplemental =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00059
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 7D96IR0PPM
<!-- Chemical data -->
| C=1377 | H=2208 | N=382 | O=442 | S=17
| molecular_weight = 31731.9 g/mol
}}
'''Pegaspargase''' {{IPAc-en|p|ə|ˈ|ɡ|æ|s|p|ər|ɡ|eɪ|z}}, trade name '''Oncaspar''', is a modified [[enzyme]] used as an [[antineoplastic]] agent. It is a form of [[L-asparaginase]]<ref>{{cite web|url=http://cancer.unm.edu/drug_dictionary.aspx?id=818 |title=UNM Cancer Center |accessdate=2007-08-28 |format= |work= |deadurl=yes |archiveurl=https://web.archive.org/web/20060903055152/http://cancer.unm.edu/drug_dictionary.aspx?id=818 |archivedate=September 3, 2006 }}</ref> which has undergone [[PEGylation]]. The drug is manufactured by Exelead, Inc. 

It is used in the treatment of [[acute lymphoblastic leukemia]].<ref name="pmid14499708">{{cite journal |author=Graham ML |title=Pegaspargase: a review of clinical studies |journal=Adv. Drug Deliv. Rev. |volume=55 |issue=10 |pages=1293–302 |year=2003 |pmid=14499708 |doi=10.1016/S0169-409X(03)00110-8}}</ref><ref>{{cite journal |vauthors=Patel SS, Benfield P |title= New drug profile: pegaspargase (Polyethylene Glycol L-Asparaginase) |journal=Clinical Immunotherapeutics |volume=5 |date=Jun 1996 |issue=6 |pages=492–496 |pmid= |doi=}}</ref>

==See also==
[[PEGylation]]

==References==
<references/>

{{Chemotherapeutic agents}}

[[Category:Antineoplastic drugs]]


{{antineoplastic-drug-stub}}